Altitude Crest Partners Inc. Legend Biotech Corp Transaction History
Altitude Crest Partners Inc.
- $234 Billion
- Q1 2024
A detailed history of Altitude Crest Partners Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Altitude Crest Partners Inc. holds 652,732 shares of LEGN stock, worth $28.9 Million. This represents 15.67% of its overall portfolio holdings.
Number of Shares
652,732
Previous 541,816
20.47%
Holding current value
$28.9 Million
Previous $32.6 Billion
12.3%
% of portfolio
15.67%
Previous 21.82%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
213Shares Held
63.6MCall Options Held
1.09MPut Options Held
525K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$485 Million0.08% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$265 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$238 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$116 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$106 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.41B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...